Genentech, a member of the Roche Group, announced that the Phase III IMpassion130 study met its co-primary endpoint of progression free survival (PFS). Results demonstrated that...
For many years, Vizient has been helping diverse suppliers refine their business strategy to more effectively compete, prosper, and grow within the health care supply chain....
Celgene Corporation will host a conference call and live audio webcast on Thursday, July 26, 2018 at 9 a.m. ET to discuss second quarter 2018 financial...
Novocure announced that Pritesh Shah has been appointed as Novocure’s Chief Commercial Officer, reporting to Novocure’s Chief Executive Officer Asaf Danziger. In this role, Shah will...
Cellerant Therapeutics, Inc., a clinical-stage company developing innovative immunotherapies for hematologic malignancies and other blood-related disorders, announced that the US Food and Drug Administration (FDA) has...
Adamis Pharmaceuticals Corporation announced that it has entered into an exclusive distribution and commercialization agreement with Sandoz Inc., a division of the Novartis Group, to commercialize...
PURE Bioscience, Inc., creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today announced that it has raised USD 500,000 in the form of a...
Healthcare information technology is evolving in many ways, and quickly so. That means health IT consulting has to change with the times, to evolve alongside the...
Agilent Technologies Inc. announced that it has entered into a definitive agreement to acquire privately-held ProZyme, Inc., a leading provider of glycan analysis reagents, kits and...
Bayer announced today the launch of myMentor, a US peer-to-peer support program for adult patients with pulmonary arterial hypertension (PAH, WHO Group 1) or chronic thromboembolic...
Bristol-Myers Squibb Company announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has recommended expanded approval of the current...
The Broad Institute of MIT and Harvard and Bayer are launching the Precision Cardiology Laboratory (PCL), a new endeavor that will pursue scientific insights aimed at...
Amgen announced that the results of two open-label extension (OLE) studies of Aimovig (erenumab-aooe) in patients with chronic and episodic migraine, respectively, will be presented at...
Thermo Fisher Scientific Inc., the world leader in serving science, and Roper Technologies, Inc., a leading diversified technology company, today announced that they have entered into...
Amazon’s announced acquisition of PillPack gives the tech giant a vehicle for disrupting the US drug distribution market – and may come with a beneficial side-effect...
Copyright © 2025 Medical Buyer maintained by Fullstack development